Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQFinancialsFinancial - MortgagesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for BETR yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Achieve Adjusted EBITDA breakeven by Q3 2026 | Better Home & Finance aims to break even on adjusted EBITDA by Q3 2026. | Broken | Adjusted EBITDA remains negative beyond Q3 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “Approximately $13.2 million of annualized reductions have been implemented; the remaining $51 million represents targeted reductions subject to execution.” “These figures represent annualized expense reductions rather than savings already realized.” |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, loss-making turnaround with some growth optionality, meaning potential from expanding products and loan volume. The long-term thesis is in a watch state: loan-volume and HELOC goals are progressing, but the path to breakeven has been uneven.
The valuation model shows BETR at a premium to peers, with optionality as the main source of divergence, but confidence in that model is low. The evidence does not specify what earnings or growth expectations the market already assumes, so the expectations gap is unclear.
Near term, consecutive earnings misses and a recent delisting-rule notice add pressure, while the risk assessment has risen to high. Loan volume grew in the first half of 2026 and HELOC demand was strong, but the adjusted EBITDA loss widened in Q3, leaving the breakeven goal behind schedule despite management reaffirming it.
The multi-year thesis depends on loan growth and HELOC expansion translating into sustained progress toward adjusted EBITDA breakeven. Near-term results could weaken further if guidance is cut; performance at sector bellwethers may provide a more favorable backdrop, while rate cuts are identified as a sector risk.
Over the next 1 to 3 years, BETR remains a fragile turnaround case: growth initiatives show progress, but repeated misses, a setback in losses, and high risk leave execution as the central test. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Monthly loan volume reaches $1.575B to $1.725B in Q2 2026 | The company is improving loan volume and revenue despite recent losses. | Intact | Monthly loan volume falls below $1.0B by Q2 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
EPS turns positive by FY 2027 | A supporting condition in Better Home & Finance Holding Co.'s published investment case. The stated target is EPS >= 0.78 USD. | Broken | EPS remains negative through FY 2027 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Quarterly revenue between $53M and $56M in Q2 2026 | A supporting condition in Better Home & Finance Holding Co.'s published investment case. The stated target is Revenue between $53M and $56M. | Broken | Revenue falls below $50M in Q2 2026 | Revenue: $1.094M FY2026-Q2; GAAP. Published target: Revenue between $53M and $56M. Same fiscal period as the stored target. Aug 11, 20261,094,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.57 → $-2.02 · observed estimates
$0.32B → $0.27B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.57 | $323,189,283 | 2 / 4 |
| 2026-07-25 | $0.57 | $323,189,283 | 2 / 4 |
| 2026-07-26 | $0.57 | $323,189,283 | 2 / 4 |
| 2026-07-27 | $0.55 | $321,099,350 | 2 / 4 |
| 2026-07-28 | $0.55 | $321,099,350 | 2 / 4 |
| 2026-07-29 | $1.07 | $321,071,000 | 4 / 6 |
| 2026-07-30 | $1.07 | $321,071,000 | 4 / 6 |
| 2026-07-31 | $1.07 | $321,071,000 | 4 / 6 |
| 2026-08-01 | $1.07 | $321,071,000 | 4 / 6 |
| 2026-08-02 | $0.55 | $321,099,350 | 3 / 4 |
| 2026-08-03 | $1.07 | $321,071,000 | 4 / 6 |
| 2026-08-04 | $1.07 | $321,071,000 | 4 / 6 |
| 2026-08-05 | $1.07 | $321,062,830 | 4 / 6 |
| 2026-08-06 | $1.07 | $321,062,830 | 4 / 6 |
| 2026-08-07 | $0.55 | $321,096,817 | 3 / 4 |
| 2026-08-08 | $1.07 | $316,571,170 | 4 / 6 |
| 2026-08-09 | $1.07 | $316,571,170 | 4 / 6 |
| 2026-08-10 | $1.07 | $316,571,170 | 4 / 6 |
| 2026-08-11 | $0.38 | $308,328,500 | 4 / 6 |
| 2026-08-12 | $0.00 | $288,920,170 | 3 / 6 |
| 2026-08-13 | $0.00 | $288,920,170 | 3 / 6 |
| 2026-08-14 | $0.55 | $321,096,817 | 3 / 4 |
| 2026-08-15 | $0.55 | $321,096,817 | 3 / 4 |
| 2026-08-16 | $0.55 | $321,096,817 | 3 / 4 |
| 2026-08-17 | $0.55 | $321,096,817 | 3 / 4 |
| 2026-08-18 | $0.55 | $321,096,817 | 3 / 4 |
| 2026-08-19 | $0.55 | $321,096,817 | 3 / 4 |
| 2026-08-20 | $0.18 | $277,932,333 | 3 / 4 |
| 2026-08-21 | $0.18 | $277,932,333 | 3 / 4 |
| 2026-08-22 | $0.18 | $277,932,333 | 3 / 4 |
| 2026-08-23 | $0.18 | $277,932,333 | 3 / 4 |
| 2026-08-24 | $0.18 | $277,932,333 | 3 / 4 |
| 2026-08-25 | $0.18 | $277,932,333 | 3 / 4 |
| 2026-08-26 | $0.18 | $277,932,333 | 3 / 4 |
| 2026-08-27 | $0.18 | $277,932,333 | 3 / 4 |
| 2026-08-28 | $0.18 | $277,932,333 | 3 / 4 |
| 2026-08-29 | $0.18 | $277,932,333 | 3 / 4 |
| 2026-08-30 | $0.18 | $277,932,333 | 3 / 4 |
| 2026-08-31 | $0.18 | $277,932,333 | 3 / 4 |
| 2026-09-01 | $0.18 | $277,932,333 | 3 / 4 |
| 2026-09-02 | $0.18 | $277,932,333 | 3 / 4 |
| 2026-09-03 | $0.18 | $277,932,333 | 3 / 4 |
| 2026-09-04 | $0.18 | $277,937,867 | 3 / 4 |
| 2026-09-05 | $0.18 | $277,937,867 | 3 / 4 |
| 2026-09-06 | $0.18 | $277,937,867 | 3 / 4 |
| 2026-09-07 | $0.18 | $277,937,867 | 3 / 4 |
| 2026-09-08 | $0.18 | $277,937,867 | 3 / 4 |
| 2026-09-09 | $0.18 | $277,937,867 | 3 / 4 |
| 2026-09-10 | $0.18 | $275,918,171 | 3 / 4 |
| 2026-09-11 | $0.18 | $275,918,171 | 3 / 5 |
| 2026-09-12 | $-1.43 | $275,918,171 | 3 / 5 |
| 2026-09-13 | $-1.71 | $275,918,171 | 4 / 5 |
| 2026-09-14 | $-1.71 | $275,918,171 | 4 / 5 |
| 2026-09-15 | $-1.71 | $275,918,171 | 4 / 5 |
| 2026-09-16 | $-1.71 | $275,918,171 | 4 / 5 |
| 2026-09-17 | $-1.71 | $275,918,171 | 4 / 5 |
| 2026-09-18 | $-1.71 | $275,918,171 | 4 / 5 |
| 2026-09-19 | $-1.71 | $275,918,171 | 4 / 5 |
| 2026-09-20 | $-1.78 | $275,918,171 | 3 / 5 |
| 2026-09-21 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-09-22 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-09-23 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-09-24 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-09-25 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-09-26 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-09-27 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-09-28 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-09-29 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-09-30 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-10-01 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-10-02 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-10-03 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-10-04 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-10-05 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-10-06 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-10-07 | $-1.78 | $275,918,171 | 4 / 5 |
| 2026-10-08 | $-1.78 | $275,925,300 | 4 / 5 |
| 2026-10-09 | $-1.78 | $275,925,300 | 4 / 5 |
| 2026-10-10 | $-1.78 | $275,925,300 | 4 / 5 |
| 2026-10-11 | $-1.78 | $275,925,300 | 4 / 5 |
| 2026-10-12 | $-1.78 | $275,925,300 | 4 / 5 |
| 2026-10-13 | $-1.91 | $271,539,500 | 4 / 5 |
| 2026-10-14 | $-1.99 | $268,678,971 | 4 / 5 |
| 2026-10-15 | $-1.99 | $268,678,971 | 3 / 5 |
| 2026-10-16 | $-1.99 | $268,678,971 | 4 / 5 |
| 2026-10-17 | $-1.99 | $268,678,971 | 4 / 5 |
| 2026-10-18 | $-1.99 | $268,633,229 | 4 / 5 |
| 2026-10-19 | $-1.99 | $268,633,229 | 4 / 5 |
| 2026-10-20 | $-1.99 | $268,633,229 | 4 / 5 |
| 2026-10-21 | $-1.99 | $268,633,229 | 4 / 5 |
| 2026-10-22 | $-1.99 | $268,633,229 | 4 / 5 |
| 2026-10-23 | $-1.99 | $268,633,229 | 4 / 5 |
| 2026-10-24 | $-1.99 | $268,633,229 | 4 / 5 |
| 2026-10-25 | $-1.99 | $268,633,229 | 4 / 5 |
| 2026-10-26 | $-1.99 | $268,633,229 | 4 / 5 |
| 2026-10-27 | $-1.99 | $268,633,229 | 4 / 5 |
| 2026-10-28 | $-2.02 | $266,879,229 | 4 / 5 |
| 2026-10-29 | $-2.02 | $266,879,229 | 4 / 5 |
| 2026-10-30 | $-2.02 | $266,879,229 | 4 / 5 |
| 2026-10-31 | $-2.02 | $266,879,229 | 4 / 5 |
| 2026-11-01 | $-2.02 | $266,879,229 | 4 / 5 |
| 2026-11-02 | $-2.02 | $266,879,229 | 4 / 5 |
| 2026-11-03 | $-2.02 | $266,879,229 | 4 / 5 |
| 2026-11-04 | $-2.02 | $266,879,229 | 4 / 5 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 7 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 4 recorded
0 raises · 0 cuts · 0 unchanged · 2 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 9, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.